Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ORGARAN

DANAPAROID SODIUM

Standard Dose
750 UNITS/0.6ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ORGARAN is listed in Drugs@FDA under application 020430 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DANAPAROID SODIUM Form and strength INJECTABLE;INJECTION - 750 UNITS/0.6ML Sponsor ASPEN GLOBAL INC Submission history Latest submission status date: 2001-06-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORGARAN is listed in Drugs@FDA under application 020430 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DANAPAROID SODIUM Form and strength INJECTABLE;INJECTION - 750 UNITS/0.6ML Sponsor ASPEN GLOBAL INC Submission history Latest submission status date: 2001-06-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ORGARAN (DANAPAROID SODIUM) | Drug Monograph | MedicHelpline